Join CBSET's partner, CILcare, who is organizing and sponsoring the Inner Ear Disorders Therapeutics Summit digital event, May 25-27, 2021.
The Inner Ear Disorders Therapeutics Summit is gathering the world’s leading biopharmaceutical companies and KOLs at the only industry-focused summit dedicated to the translation and clinical development of novel gene therapy, cell therapy and small molecule-based approaches to treat inner ear disorders, with the aim to progress the industry towards the first clinically approved therapy.
CILcare's CEO and Co-Founder, Celia Belline, will be speaking at this event on: Expanding drug portfolio in hearing, with fast-track development strategies.
Related CBSET Services:
Related CBSET & CILcare Publications:
- Intracochlear Drug Delivery Systems: A Novel Approach Whose Time Has Come. Peppi M, Marie A, Belline C, Borenstein JT. Expert Opinion in Drug Delivery. 2018 Feb 26. doi: 10.1080/17425247.2018.1444026.
by Michael Naimark, Director of Business Development, CBSET, Inc. and Marie-Pierre Pasdelou, PharmD, founder and the Chief Development Officer, CILcare
World Pharma Today: Stem Cell and Regenerative Therapies for Hearing Loss
by Michael Naimark, Director of Business Development, CBSET, Inc. and Marie-Pierre Pasdelou, PharmD, founder and the Chief Development Officer, CILcare